𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of the CD34 antigen distinguishes Kaposi's sarcoma from pseudo-Kaposi's sarcoma (acroangiodermatitis)

✍ Scribed by J. KANITAKIS; D. NARVAEZ; A. CLAUDY

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
856 KB
Volume
134
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prevalence of Kaposi's sarcoma-associate
Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain
✍ SΓ­lvia de SanjosΓ©; Vickie Marshall; Judit SolΓ ; Virgilio Palacio; Rosa Almirall; πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 69 KB

## Abstract Transmission routes of Kaposi's sarcoma‐associated herpesvirus (KSHV) in the general population are poorly understood. Whereas sexual transmission appears to be common in homosexual men, the evidence for heterosexual transmission is less convincing. In our study, prevalence of KSHV infe

Estimating the effect of zidovudine on K
Estimating the effect of zidovudine on Kaposi's sarcoma from observational data using a rank preserving structural failure-time model
✍ Marshall M. Joffe; Donald R. Hoover; Lisa P. Jacobson; Lawrence Kingsley; Joan S πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 214 KB πŸ‘ 2 views

Researchers commonly express scepticism about using observational data to estimate the effect of a treatment on an outcome the treatment is intended to affect. In this paper, we consider using data from the Multicenter AIDS Cohort Study (MACS) to determine whether zidovudine prevents the development